Candidates Targeting Parkinson’s Disease and ALS Advance in Discovery Phase
June 26, 2018 at 04:00 AM EDT
Source: Streetwise Reports 06/26/2018 This precision medicine company, focused on neurodegenerative diseases, has selected antibody candidates to advance into the final phase of discovery. In a June 26 press release, ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) [...]
